Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-10

Clinical Trial Update: Dutasteride for the Reduction of Alcohol Use in Male Drinkers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dutasteride for reducing alcohol use in male drinkers completed; results posted on ClinicalTrials.gov in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

Sponsor: UConn Health | Conditions: Alcoholism, Alcohol Abuse | Phase 4 | Status: COMPLETED | Results posted: 2017-02-10